Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Wilmink Insider Profile
4 Followers
Michael Wilmink, Director at Eupraxia Pharmaceuticals, holds 224.87K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX). Most recently, Michael Wilmink Bought C$1,900 shares of Eupraxia Pharmaceuticals on Sep 12, 2024 for an estimated value of 5.14K.
Profitable Transactions
8 out of 10 Profitable Transactions
Average Return
+73.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Wilmink's holdings
Insider Roles
Director
Roles that Michael Wilmink holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 10, 2022 - Jun 10, 2023
Return:+520.50%
The most profitable trade made by Michael Wilmink
Michael Wilmink's Trading History
List of latest transactions for each holding click on a transaction to see Michael Wilmink's performance on stock
You May Also Like
Michael Wilmink insider profile FAQ
What is the percentage of profitable transactions made by Michael Wilmink?
The percentage of profitable transactions made by Michael Wilmink is 80%.
What is the average return per transaction made by Michael Wilmink?
The average return per transaction made by Michael Wilmink is 73.40%.
What stocks does Michael Wilmink hold?
Michael Wilmink holds: TSE:EPRX stocks.
What was Michael Wilmink’s latest transaction?
Michael Wilmink latest transaction was an Informative Buy of C$5.14K.
What was Michael Wilmink's most profitable transaction?
Michael Wilmink’s most profitable transaction was an Informative Buy of TSE:EPRX stock on June 10, 2022. The return on the trade was 520.50%.
What is Michael Wilmink's role in Eupraxia Pharmaceuticals?
Michael Wilmink's role in Eupraxia Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.